Cargando…

An Exploratory Study of a Novel Combined Therapeutic Modality for Obsessive-Compulsive Disorder

Objective: To explore whether a systematic combined therapeutic modality (CTM) could quickly and effectively improve the severity of obsessive–compulsive disorder (OCD) and the insight of OCD patients. Methods: Included in this study were 100 patients with OCD according to the 5th Edition of the Dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yueqi, Yang, Hangyi, Zhu, Cheng, Jiang, Xiaoying, Zhu, Wenjing, Liang, Yan, Ma, Lisha, Wang, Yunzan, Tang, Wenxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599080/
https://www.ncbi.nlm.nih.gov/pubmed/36291243
http://dx.doi.org/10.3390/brainsci12101309
_version_ 1784816507316862976
author Huang, Yueqi
Yang, Hangyi
Zhu, Cheng
Jiang, Xiaoying
Zhu, Wenjing
Liang, Yan
Ma, Lisha
Wang, Yunzan
Tang, Wenxin
author_facet Huang, Yueqi
Yang, Hangyi
Zhu, Cheng
Jiang, Xiaoying
Zhu, Wenjing
Liang, Yan
Ma, Lisha
Wang, Yunzan
Tang, Wenxin
author_sort Huang, Yueqi
collection PubMed
description Objective: To explore whether a systematic combined therapeutic modality (CTM) could quickly and effectively improve the severity of obsessive–compulsive disorder (OCD) and the insight of OCD patients. Methods: Included in this study were 100 patients with OCD according to the 5th Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), for a 2-week short-term treatment. They were assigned to a drug-alone group (n = 57), and a CTM group (n = 43) using drug treatment in combination with cognitive behavioral treatment (CBT) and repetitive transcranial magnetic stimulation (rTMS). The therapeutic outcome was assessed by the Yale–Brown Obsessive–Compulsive Scale (Y-BOCS), Brown Assessment of Beliefs Scale (BABS), 24-item Hamilton Depression Scale (HAMD-24) and Hamilton Anxiety Scale (HAMA) before and after treatment. All data were treated with SPSS25.0 Software. Results: After the 2-week treatment, the success rate in the CTM group was significantly higher than that in the drug-alone group. Y-BOCS overall and factor scores were decreased as compared with those before treatment in both groups. HAMD, HAMA and BABS overall scores were all decreased after treatment in the CTM group. In addition, compared with the drug-alone group, the Y-BOCS overall score and factor score, HAMD overall score and HAMA overall score were all decreased significantly in CTM group, while the Y-BOCS score reduction rate was increased significantly. Insight was improved in eight cases (57.14%) in the CTM group containing 14 cases with poor insight. Multinomial logistic regression analysis showed that CTM was beneficial for the insight improvement of OCD patients (OR = 91.04–139.68); this improvement was more pronounced in patients with low baseline BABS overall scores (OR = 0.07). Conclusion: CTM may be an effective short-term strategy to improve the severity of OCD and insight of OCD patients and, therefore, is worthy of clinical promotion and application.
format Online
Article
Text
id pubmed-9599080
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95990802022-10-27 An Exploratory Study of a Novel Combined Therapeutic Modality for Obsessive-Compulsive Disorder Huang, Yueqi Yang, Hangyi Zhu, Cheng Jiang, Xiaoying Zhu, Wenjing Liang, Yan Ma, Lisha Wang, Yunzan Tang, Wenxin Brain Sci Article Objective: To explore whether a systematic combined therapeutic modality (CTM) could quickly and effectively improve the severity of obsessive–compulsive disorder (OCD) and the insight of OCD patients. Methods: Included in this study were 100 patients with OCD according to the 5th Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), for a 2-week short-term treatment. They were assigned to a drug-alone group (n = 57), and a CTM group (n = 43) using drug treatment in combination with cognitive behavioral treatment (CBT) and repetitive transcranial magnetic stimulation (rTMS). The therapeutic outcome was assessed by the Yale–Brown Obsessive–Compulsive Scale (Y-BOCS), Brown Assessment of Beliefs Scale (BABS), 24-item Hamilton Depression Scale (HAMD-24) and Hamilton Anxiety Scale (HAMA) before and after treatment. All data were treated with SPSS25.0 Software. Results: After the 2-week treatment, the success rate in the CTM group was significantly higher than that in the drug-alone group. Y-BOCS overall and factor scores were decreased as compared with those before treatment in both groups. HAMD, HAMA and BABS overall scores were all decreased after treatment in the CTM group. In addition, compared with the drug-alone group, the Y-BOCS overall score and factor score, HAMD overall score and HAMA overall score were all decreased significantly in CTM group, while the Y-BOCS score reduction rate was increased significantly. Insight was improved in eight cases (57.14%) in the CTM group containing 14 cases with poor insight. Multinomial logistic regression analysis showed that CTM was beneficial for the insight improvement of OCD patients (OR = 91.04–139.68); this improvement was more pronounced in patients with low baseline BABS overall scores (OR = 0.07). Conclusion: CTM may be an effective short-term strategy to improve the severity of OCD and insight of OCD patients and, therefore, is worthy of clinical promotion and application. MDPI 2022-09-28 /pmc/articles/PMC9599080/ /pubmed/36291243 http://dx.doi.org/10.3390/brainsci12101309 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Huang, Yueqi
Yang, Hangyi
Zhu, Cheng
Jiang, Xiaoying
Zhu, Wenjing
Liang, Yan
Ma, Lisha
Wang, Yunzan
Tang, Wenxin
An Exploratory Study of a Novel Combined Therapeutic Modality for Obsessive-Compulsive Disorder
title An Exploratory Study of a Novel Combined Therapeutic Modality for Obsessive-Compulsive Disorder
title_full An Exploratory Study of a Novel Combined Therapeutic Modality for Obsessive-Compulsive Disorder
title_fullStr An Exploratory Study of a Novel Combined Therapeutic Modality for Obsessive-Compulsive Disorder
title_full_unstemmed An Exploratory Study of a Novel Combined Therapeutic Modality for Obsessive-Compulsive Disorder
title_short An Exploratory Study of a Novel Combined Therapeutic Modality for Obsessive-Compulsive Disorder
title_sort exploratory study of a novel combined therapeutic modality for obsessive-compulsive disorder
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599080/
https://www.ncbi.nlm.nih.gov/pubmed/36291243
http://dx.doi.org/10.3390/brainsci12101309
work_keys_str_mv AT huangyueqi anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT yanghangyi anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT zhucheng anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT jiangxiaoying anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT zhuwenjing anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT liangyan anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT malisha anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT wangyunzan anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT tangwenxin anexploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT huangyueqi exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT yanghangyi exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT zhucheng exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT jiangxiaoying exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT zhuwenjing exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT liangyan exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT malisha exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT wangyunzan exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder
AT tangwenxin exploratorystudyofanovelcombinedtherapeuticmodalityforobsessivecompulsivedisorder